Skip to main content

Advertisement

Table 1 Baseline and End of Study Anthropometric and Metabolic Measures in Controls and Cases

From: Impact of an exercise program on acylcarnitines in obesity: a prospective controlled study

  Baseline P+ End of the Study P+ A vs. C‡ B vs. D‡
  Control (A) n = 15 Case (B) n = 17   Control (C) n = 15 Case (D) n = 17    
Age, y § 21.5 ± 2.19 20.3 ± 1.44 0.08 72.40 (65.66 – 82.08) 76.30 (69.90 – 82.22) 0.39 0.80 0.0003*
Weight, kg. 72.20 (66.55 – 80.75) 81.10 (72.08–84.7) 0.06      
Height, cm 157 (151.26 – 163.47) 161 (156 - 164) 0.24      
BMI kg/m2 28.89 (27.78 – 31.12) 30.50 (28.50 – 32. 69) 0.15 29.10 (27.73. 30.88) 28.80 (27.50 – 30.78) 0.74 0.76 0.0002*
FM kg 26.7 (23.15 – 31.26) 32.6 (23.51 – 34.4) 0.08 27.60 (23.50 – 31.01) 29.40 (23.12 – 33.07) 0.67 0.58 0.0005*
FFM kg 45.70 (42.13 – 48.26) 48.70 (46.20 – 50.29) 0.08 44.80 (41.75 – 47.94) 47.90 (45.80 – 49.39) 0.06 0.13 0.03*
Waist cm 83 (80.38 – 88) 86.40 (82.02 – 91.98) 0.24 82.50 (79.76 – 86.15) 83 (79.50 – 86) 0.74 0.11 < 0.0001*
Hip cm 108 (102.26 – 110.62) 112.5 (105.04 – 115.46) 0.07 106.5 (102.52 – 108.73) 108 (103 – 111) 0.76 0.54 0.0002*
Waist to Hip Ratio 0.79 (0.76 - 0.81) 0.78 (0.77 - 0.81) 0.80 0.77 (0.75 - 0.80) 0.78 (0.75 - 0.79) 0.63 0.27 0.04*
Adiponectin ug/ml 11.54 (7.88 – 15.26) 11.72 (7.29 – 15.06) 0.61 12.33 (8.36 – 15.60) 15.76 (9.96 – 23.44) 0.32 0.80 < 0.0001*
Leptin ng/ml 30.33 (25.30 – 36.06) 28.31 (23.82 – 35.12) 0.71 29.42 (21.51 – 37) 18.13 (12.94 – 24.31) 0.002* 0.45 0.03*
TNFa pg/ml 4.44 (4.10 – 6.14) 4.33 (2.90 – 5.31) 0.25 5.05 (4.12 – 6.76) 4.10 (3.53 – 4.98) 0.036* 0.12 0.93
Insulin, mg/dl 13.72 (11.47 – 24.95) 12.01 (8.64–16.74) 0.14 12.73 (10.70 – 19.43) 12.89 (6.42 – 14.37) 0.12 0.01* 0.17
Glucose, mg/dl 84 (80.26 – 88) 74 (73–78.96) 0.003* 86 (82.26 – 87) 82 (76.01 – 87) 0.39 0.80 0.05*
CHOL, mg/dl 78 (59.05 – 149.02) 78 (62.03 – 111.79) 0.69 78 (65.79 – 113) 66 (59.03 – 99-95) 0.15 0.59 0.33
TGL mg/dl 160 (144.52 – 182.41) 153 (144.04 – 186.98) 0.87 165 (149.70 – 186.73) 168 (152.01 – 184. 91) 0.79 0.42 0.12
HDL mg/dl 49 (36.26 – 54.94) 45 (41.01 – 71.74) 0.39 45 (39.26 – 53.47) 44 (40 – 55.93) 0.98 0.84 0.32
LDL mg/dl 104 (98–109.47) 105 (102.01 – 109.98) 0.50 95 (90 – 102.41) 92 (80.12 – 97.98) 0.36 0.20 0.0001*
HOMA 2.88 (2.29 – 5.20) 2.22 (1.59 – 3.01) 0.047* 2.58 (2.29 – 4.20) 2.29 (1.47 – 2.83) 0.15 0.06 0.40
FFA mEq/L 0.40 (0.30 - 0.50) 0.40 (0.30 - 0.59) 0.39 0.50 (0.32 - 0.60) 0.40 (0.40 - 0.60) 0.86 0.27 0.23
  1. ^ Results are reported in median and 95% Confidence Interval, except age (§), which is mean ± SD.
  2. FFA denotes Free-fat Mass, FM fat mass, BMI body mass index, W/H Waist to Hip Ratio, TNFa tumor necrosis factor alpha, CHOL Cholesterol, TGL Triglycerides, HOMA Homeostatic Model Assessment, HDL high-density lipoprotein, LDL low-density lipoprotein, FFA Free fatty acids.
  3. +p Values where calculated by Mann–Whitney Test.
  4. p Values where calculated by Wilcoxon Rank Test.
  5. * Significant Result p < 0.05.